Pigment Cell and Melanoma Research

Aims & Scope

Pigment Cell & Melanoma Researchpublishes manuscripts on all aspects of pigment cells including development, cell and molecular biology, genetics, diseases of pigment cells including melanoma.

Papers that provide insights into the causes and progression of melanoma including the process of metastasis and invasion, proliferation, senescence, apoptosis or gene regulation are especially welcome, as are papers that use the melanocyte system to answer questions of general biological relevance.

Papers that are purely descriptive or make only minor advances to our knowledge of pigment cells or melanoma in particular are not suitable for this journal.

Keywords Pigment Cell & Melanoma Research, cell biology, melatonin, biochemistry, chemistry, comparative biology, dermatology, developmental biology, genetics, hormones, intracellular signalling, melanoma, molecular biology, ocular and extracutaneous melanin, pharmacology, photobiology, physics, pigmentary disorders

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Medline
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 1,790.00 GBP. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference

  Citation: 504

  Authors: K., H. W., T., I., I., C. C. E., B. K., T., C., A. Y., D., N., I. C., N., L., R., Y., S. K., M., A.

• Cancer stem cells versus phenotype‐switching in melanoma

  Citation: 424

  Authors: Keith S., Colin R.

• Melanins and melanogenesis: methods, standards, protocols

  Citation: 410

  Authors: Marco, Kazumasa, Alessandra, Stefania, José‐Carlos, Daniela, Paul, Alessandro, Mauro, Tadeusz, John D., Shosuke

• Melanins and melanogenesis: from pigment cells to human health and technological applications

  Citation: 385

  Authors: Marco, Kazumasa, Fabio, Eduardo, Josè Carlos, Stephane, Ismael, Ghanem, Koike, Paul, Alessandro, Clara, Tadeusz, John D., Luigi, Fabio A., Alessandra, Shosuke

• L‐tyrosine and L‐dihydroxyphenylalanine as hormone‐like regulators of melanocyte functions

  Citation: 383

  Authors: Andrzej, Michal A., John

• <scp>PD</scp>‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐<scp>PD</scp>‐1/<scp>PD</scp>‐<scp>L</scp>1 clinical trials

  Citation: 351

  Authors: Jason, Ricardo E., Alexander M., Hojabr, James S., Jessica, Jennifer H., Richard F., John F., Georgina V., Peter, Richard A.

• Current challenges in understanding melanogenesis: bridging chemistry, biological control, morphology, and function

  Citation: 330

  Authors: John D, Dana, Kazumasa, Shosuke

• Fifteen-year quest for microphthalmia-associated transcription factor target genes

  Citation: 302

  Authors: Yann, Mickael, Robert, Corine

• The <scp>YUMM</scp> lines: a series of congenic mouse melanoma cell lines with defined genetic alterations

  Citation: 299

  Authors: Katrina, Jake Xiao, Goran, William, Marcus W.

• PLX4032, a selective BRAF ^V600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF ^WT melanoma cells

  Citation: 284

  Authors: Ruth, Wengeng, Antonella, Elaine, Fabio, Stephan, Michael, James P., Yuval, Mario